Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vacci...
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/164086 |
| _version_ | 1826127364676911104 |
|---|---|
| author | Tan, Sharon H. X. Cook, Alex R. Heng, Derrick Ong, Benjamin Lye, David C. Tan, Kelvin B. |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Tan, Sharon H. X. Cook, Alex R. Heng, Derrick Ong, Benjamin Lye, David C. Tan, Kelvin B. |
| author_sort | Tan, Sharon H. X. |
| collection | NTU |
| description | Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking. |
| first_indexed | 2024-10-01T07:07:42Z |
| format | Journal Article |
| id | ntu-10356/164086 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T07:07:42Z |
| publishDate | 2023 |
| record_format | dspace |
| spelling | ntu-10356/1640862023-01-04T06:44:09Z Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age Tan, Sharon H. X. Cook, Alex R. Heng, Derrick Ong, Benjamin Lye, David C. Tan, Kelvin B. Lee Kong Chian School of Medicine (LKCMedicine) National Centre for Infectious Diseases Tan Tock Seng Hospital National University of Singapore Science::Medicine Urgent Care Encounters Vision Network Since it was first identified in early November 2021, the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread quickly and replaced the B.1.617.2 (delta) variant as the dominant variant in many countries. Data on the real-world effectiveness of vaccines against the omicron variant in children are lacking. 2023-01-04T06:44:08Z 2023-01-04T06:44:08Z 2022 Journal Article Tan, S. H. X., Cook, A. R., Heng, D., Ong, B., Lye, D. C. & Tan, K. B. (2022). Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age. New England Journal of Medicine, 387(6), 525-532. https://dx.doi.org/10.1056/NEJMoa2203209 0028-4793 https://hdl.handle.net/10356/164086 10.1056/NEJMoa2203209 35857701 2-s2.0-85136339464 6 387 525 532 en New England Journal of Medicine © 2022 Massachusetts Medical Society. All rights reserved. |
| spellingShingle | Science::Medicine Urgent Care Encounters Vision Network Tan, Sharon H. X. Cook, Alex R. Heng, Derrick Ong, Benjamin Lye, David C. Tan, Kelvin B. Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age |
| title | Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age |
| title_full | Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age |
| title_fullStr | Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age |
| title_full_unstemmed | Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age |
| title_short | Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age |
| title_sort | effectiveness of bnt162b2 vaccine against omicron in children 5 to 11 years of age |
| topic | Science::Medicine Urgent Care Encounters Vision Network |
| url | https://hdl.handle.net/10356/164086 |
| work_keys_str_mv | AT tansharonhx effectivenessofbnt162b2vaccineagainstomicroninchildren5to11yearsofage AT cookalexr effectivenessofbnt162b2vaccineagainstomicroninchildren5to11yearsofage AT hengderrick effectivenessofbnt162b2vaccineagainstomicroninchildren5to11yearsofage AT ongbenjamin effectivenessofbnt162b2vaccineagainstomicroninchildren5to11yearsofage AT lyedavidc effectivenessofbnt162b2vaccineagainstomicroninchildren5to11yearsofage AT tankelvinb effectivenessofbnt162b2vaccineagainstomicroninchildren5to11yearsofage |